Derek Crager, CEO and Founder of Practical AI, discusses how his Amazon experience led to creating Pocket Mentor, the world's ...

Denver Industrial worked with Grundfos to select a solution with an integrated variable-frequency drive (VFD) and industry-leading energy ... The installation crew completed piping in the morning, ...

This year the annual National Night Out event in Solano County was moved from its more traditional August date to the second ...

General Motors Co is set to announce plans on Wednesday to put into production an interchangeable "family" of electric vehicle (EV) drive systems and motors, boosting manufacturing efficiencies as it ...

Temperature Control Range and Dynamic Response Capability of High and Low Temperature Integrated Circulation Machines The ...

The Community Access Project for Eureka (CAPE) has kicked off its annual “Halloween Costume Drive” for local infants, children and youth in need. Through the drive, CAPE partners with local shelters ...

The 340B drug discount program incentivizes hospitals to purchase outpatient clinics and prescribe more and higher-cost drugs — behaviors that tend to increase costs for the federal government and ...

The nonprofit Music Drives Us donated new musical instruments, valued at over $65,000, to Quincy's middle school band program. The donation will supplement the district's aging instrument stock and ...

• Emma Rude ( news-shield.com) — Emma Rude, 88, passed away in Crofton where she contributed to local businesses. Known for ...

BELLEVUE, Wash., September 16, 2025--(BUSINESS WIRE)--Nintex, a global leader in AI-powered process automation and application development, today announced the launch of its new Nintex Partner Program ...

Additionally, the company announced the appointment of Brian Kuettel as Global Head of Partner Strategy and Sales. In this role, Kuettel will lead the company’s global partner organisation, driving ...

Hoth has submitted a Clinical Trial Application (CTA) to the European Medicines Agency (EMA) to expand its ongoing Phase II trial of HT-001, a novel topical therapeutic for EGFR inhibitor-induced skin ...